Iindaba

I-VANCOUVER, BC, Feb. 22, 2023 /PRNewswire/ - Imarike yehlabathi ekhuthaza ukukhula kwamathambo ixabisa i-2.22 yeebhiliyoni zeedola ngo-2022 kwaye kulindeleke ukuba ikhule kwi-CAGR ye-5.5% kwixesha lesimo sezulu. uphando oluvelayo. Ukukhula kwengeniso kwimakethi yokukhuthaza ukukhula kwamathambo kuqhutywa kukwanda kwezehlo zokuqhekeka kunye nesifo samathambo, ukonyuka kwemfuno yonyango olungaphazamisiyo kunye nolungenazintlungu, kunye nokwanda kwabantu abadala.
Cela ikopi yesampulu yasimahla (funda ulwakhiwo olupheleleyo lwale ngxelo [isishwankathelo + itheyibhile yeziqulatho]) @ https://www.emergenresearch.com/request-sample/1373
Ukonyuka kwezehlo zokuqhekeka kunye nezifo zamathambo ezinje nge-osteoporosis kunye ne-osteoarthritis yenye yezona zinto ziqhuba ukukhula kweengeniso zentengiso. Ehlabathini lonke, omnye kwabasetyhini abathathu kunye nomnye kwabahlanu kwindoda engaphezu kweminyaka engama-50 bafumana i-osteoporotic fracture, ngokutsho kwe-International Osteoporosis Foundation. Ngaphezu koko, ukonyuka kwabemi be-geriatric kuthandeka ngakumbi kwi-fractures, ekulindeleke ukuba yonyuse imfuno yezinto ezikhuthaza ukukhula kwamathambo. Ukongezelela, imfuno yonyango olungenakuthintelwa kunye nolungenabuhlungu luqhuba ukuqaliswa kwezinto ezikhuthaza ukukhula kwamathambo njengoko zinika inketho esebenzayo yokungabikho kokuhlinzwa kwonyango lwezaphulelo kunye nezifo.
Ixabiso eliphezulu lezinto ezikhuthaza ukukhula kwamathambo sesinye sezona zinto zithintela ukukhula kwemarike yokukhuthaza ukukhula kwamathambo. Iindleko eziphezulu zezi zixhobo zinciphisa ukuhanjiswa kwazo, ngakumbi kumazwe anengeniso ephantsi kunye nephakathi apho iindleko zonyango ziyinkxalabo enkulu. Ukongeza, ukunqongophala kolwazi kunye nemigaqo-nkqubo yembuyekezo enqongopheleyo kweminye imimandla ikwasisithintelo esikhulu ekukhuleni kwemarike.
Imakethi yehlabathi ekhuthaza ukukhula kwamathambo kulindeleke ukuba ifikelele kwi-CAGR ye-5.5% ngexesha loqikelelo ngengeniso eyonyukayo ukusuka kwi-2.22 yeebhiliyoni zeedola ngo-2022 ukuya kwi-3.80 yeebhiliyoni zeedola ngo-2032. kunye nezifo, ukwanda kwabemi be-geriatric kunye nemfuno yonyango olungangeneleli kunye nolungenantlungu.
I-Emergen Research inikezela ngesaphulelo sexeshana (fumana ikopi yakho ngoku ngexabiso elincitshisiweyo) @ https://www.emergenresearch.com/request-discount/1373
Imakethi yezinto ezikhuthaza ukukhula kwamathambo iphantsi kotshintsho olukhulu ngexesha loqikelelo. Okwangoku kukho umkhwa obhekiselele ekuphuhlisweni kwezinto ezintsha kunye neziphuculweyo ezikhuthaza ukukhula kwamathambo ezinokuthi zisetyenziswe kungenelelo olwahlukeneyo lotyando. Ezi zixhobo zitsha ziyilelwe ukuba zisebenze ngakumbi, zichaneke ngakumbi kwaye zisebenzise izinto ezininzi kunezixhobo zemveli. Ukongezelela, kukho umkhwa wokusetyenziswa kwezinto ezikhuthaza ukukhula kwamathambo kwiinkqubo ezintsha kunye nezintsha ezifana nokuhlinzwa kwe-spinal fusion, inkqubo yotyando esetyenziselwa ukunyanga iifractures kunye nezifo zomqolo.
Iinkampani eziphambili ezibandakanyiweyo kwingxelo yemarike yi-Isto Biologics, uJOHNSON noJohnson, i-MEDTRONIC PLC., i-Orthofix Medical Inc., i-STRYKER CORPORATION, i-Terumo Corporation, i-ZIMMER BIOMET HOLDINGS, i-IGEA Pharma, i-Manamed Inc. kunye ne-THERAGEN ETEX CO., LTD.
Ezi nkampani zibandakanyeka ngokubonakalayo kumanyathelo acwangcisiweyo afana ne-M&A, intsebenziswano kunye nentsebenziswano ukwandisa ipotfoliyo yemveliso yazo nokomeleza ubukho bazo kwimarike. Umzekelo, ngoSeptemba ka-2022, iBioventus LLC yabhengeza ukufunyanwa kwe-Emerge Medical, inkampani ebonelela ngokhathalelo oluphezulu lwenxeba kunye neemveliso zonyango loxinzelelo, ukwandisa ipotfoliyo yayo yeemveliso zamathambo kunye ne-biosurgical.
Jonga iNgcaciso yeNgxelo epheleleyo + Indlela yoPhando + Imixholo + Infographics @ https://www.emergenresearch.com/industry-report/bone-growth-stimulator-market
USA, Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, Korea, Rest of Asia Pacific, Brazil, Rest of Latin America, Saudi Arabia, UAE, South Africa , Turkey, ukuphumla kuMbindi Mpuma kunye neAfrika
I-Orthofix US LLC, i-Stryker, iiNkonzo zoShishino lweSixhobo sezoNyango, i-Inc., i-Bioventus, i-Medtronic, i-DJO, i-LLC, i-Zimmer Biomet, i-Arthrex, i-Inc., i-Terumo Corporation, i-Ossatec Benelux BV
Iimfuno zokwenziwa ngokwezifiso zinokucelwa kule ngxelo [isiko] @ https://www.emergenresearch.com/request-for-customization/1373
Ngenjongo yale ngxelo, i-Emergen Research iye yahlula-hlula imarike ye-Bone Growth Stimulants yokuthengisa ngokusekelwe kwimveliso, ukusetyenziswa, ukusetyenziswa kokuphela kunye nommandla:
I-Sterrilization Container Systems Market ngohlobo lweMveliso (i-Perforated Sterilization Container Systems, enye), iTekhnoloji, Uhlobo lweMpahla (iAluminiyam, iStainless Steel, iPlastiki, enye), iMimandla. Uqikelelo ukuya kuthi ga ngo-2032
Ukuchaneka kweMakethe yeMveliso yeeMveliso kunye neeNkonzo (i-Hardware, iSoftware, enye), iTekhnoloji (iTekhnoloji yeGround, iTekhnoloji yeAviation), Uhlobo lweNkqubo, iSicelo (IiCereals, i-Oilseeds & Pulses, enye), i-Forecast nguMmandla ukuya kwi-2032
I-Smart Insulin Delivery Patches Market ngeMveliso (IiPatches zokuHlola kunye neePatches zeTransdermal), ngokuSetyenziswa kokuphela (Izibhedlele, iZibonelelo zokuNakekelwa kweKhaya, iiKlinikhi), ngoMmandla. Uqikelelo ukuya kuthi ga ngo-2032
IMarike yeeSutures zokuSebenza ngemveliso, ngokohlobo, ngokusetyenziswa (utyando lwentliziyo, utyando ngokubanzi, utyando lobufazi, utyando lwamathambo, abanye), ngokusetyenziswa kokuphela kunye nommandla. Uqikelelo ukuya kuthi ga ngo-2032
Imarike yamatayara angaphandle kwendlela ngohlobo lwezixhobo, ngokuphuma kwamandla, ngohlobo lwesixhobo soshishino, ngohlobo lwetayara, ngokobungakanani bomphetho, ngokusetyenziswa (izixhobo zokwakha kunye nemigodi, iitrektara zezolimo kunye nezixhobo zoshishino), nangommandla. Uqikelelo ukuya kuthi ga ngo-2032
I-Market Pump ye-Infusion ngohlobo (Positive, Syringe, Elastomeric, Insulin, Enteral and Implantable), Isicelo (Isifo seswekile, i-Oncology kunye noLawulo lweentlungu), Ukuphela kokusetyenziswa kunye nommandla. Uqikelelo ukuya kuthi ga ngo-2030
IMarike yeeNkqubo zoKhuseleko lwaseLwandle ngeSixokelelwano (iNkqubo yokuNika iNgxelo yoKhuseleko lweNqanawa, iNkqubo yokuQonga ngokuzenzekelayo, iNkqubo yokuLandela ukuLawulwa kunye neNkqubo yokuchongwa, njl.), NgeSicelo, nguMsebenzisi wokuGqibela, ngoMmandla. Uqikelelo ukuya kuthi ga ngo-2032
Ukulinganisa imarike yokufumanisa kunye nokuphendula ngecandelo (izisombululo kunye neenkonzo), ngokusasazwa (ilifu kunye neendawo), ngobukhulu bentlangano, ngokuthe nkqo, kunye nommandla. Uqikelelo ukuya kuthi ga ngo-2032
Imakethi yesazisi esinatyisiweyo ngokohlobo lwesazisi (ibhayometriki vs. engeyiyo eyebhayometriki), ngokobungakanani bombutho (SMB vs. ishishini elikhulu), ngokusetyenziswa kwesiphelo (sobuqu vs. corporate), ngokuthe nkqo, ngokommandla. Uqikelelo ukuya kuthi ga ngo-2032
Imakethi yonikezelo lwezempilo encediswa yiTekhnoloji ngemodeli (ukhathalelo olungxamisekileyo oluchanekileyo kunye nesibhedlele sasekhaya), ngohlobo, ngokukhethekileyo, ngendlela yokhathalelo, ngomsebenzisi wokugqibela kunye nangommandla, uqikelelo lwe-2032
I-Emergen Research luphando kunye nefemu yokubonisana enikezela ngeengxelo zophando ezihlanganisiweyo, iingxelo zophando ezilungelelanisiweyo, kunye neenkonzo zengcebiso. Izisombululo zethu zigxile ngokupheleleyo kwiinjongo zakho zokuchonga, ukufumanisa kunye nokuhlalutya utshintsho kwindlela yokuziphatha yabathengi ngokusekelwe kumanani abantu kunye namashishini, kwaye uncede abathengi benze izigqibo ezingcono zoshishino. Senza uphando lwemarike, ukubonelela ngoku-umhla kunye nophando olusekelwe kubungqina kuwo wonke amashishini aquka ukhathalelo lwempilo, iindawo zokuthintela, iikhemikhali, iintlobo, kunye namandla. Sihlala sihlaziya iimveliso zethu zophando ukugcina abathengi bethu besazi ngentsingiselo yemarike yamva nje. UPhando oluPhumayo luqeshe abahlalutyi abanamava kwiinkalo ezahlukeneyo zobuchwephesha. Amava ethu oshishino kunye nokukwazi ukuphuhlisa izisombululo ezithile kuwo nawuphi na umngeni wophando unika abathengi bethu ithuba lokufumana umda ngaphezu kwabo bakhuphisana nabo.